Bodycote (BOY.L) Stock Price
Bodycote Price
Over the last 19 years Bodycote grew revenue by 2.5% annually, reaching 757.10 M GBP. Earnings per share have declined at 3.7% per year over the last 19 years. For Bodycote, the net margin of 2.6% is up versus 0.1% a few years ago. At today's price the dividend yield works out to roughly 328.32%. The payout ratio is around 214% of earnings. The dividend has grown at 6.5% per year over the past 19 years. The consensus 12-month price target for Bodycote is 831.30 GBP, about 1,191,728.0% above where the stock trades today. Of 16 analysts, 14 rate the stock a buy — an overall Buy consensus. The stock trades about 9% above its 52-week low.
Bodycote stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Bodycote over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Bodycote stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Bodycote's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Bodycote Price |
|---|---|
| 7/24/2026 | 0.07 GBP |
| 7/23/2026 | 0.07 GBP |
| 7/22/2026 | 0.07 GBP |
| 7/21/2026 | 0.07 GBP |
| 7/20/2026 | 0.07 GBP |
| 7/17/2026 | 0.07 GBP |
| 7/16/2026 | 0.07 GBP |
| 7/15/2026 | 0.07 GBP |
| 7/14/2026 | 0.07 GBP |
| 7/13/2026 | 0.06 GBP |
| 7/10/2026 | 0.06 GBP |
| 7/9/2026 | 0.06 GBP |
| 7/8/2026 | 0.06 GBP |
| 7/7/2026 | 0.06 GBP |
| 7/6/2026 | 0.07 GBP |
| 7/3/2026 | 0.07 GBP |
| 7/2/2026 | 0.07 GBP |
| 7/1/2026 | 0.07 GBP |
| 6/30/2026 | 0.07 GBP |
| 6/29/2026 | 0.07 GBP |
| 6/26/2026 | 0.07 GBP |
| 6/25/2026 | 0.07 GBP |
| 6/24/2026 | 0.07 GBP |
| 6/23/2026 | 0.07 GBP |
| 6/22/2026 | 0.07 GBP |
| 6/19/2026 | 0.07 GBP |
| 6/18/2026 | 0.07 GBP |
| 6/17/2026 | 0.07 GBP |
| 6/16/2026 | 0.07 GBP |
| 6/15/2026 | 0.07 GBP |
| 6/12/2026 | 0.07 GBP |
| 6/11/2026 | 0.07 GBP |
| 6/10/2026 | 0.07 GBP |
| 6/9/2026 | 0.07 GBP |
| 6/8/2026 | 0.07 GBP |
| 6/5/2026 | 0.07 GBP |
| 6/4/2026 | 0.08 GBP |
| 6/3/2026 | 0.08 GBP |
| 6/2/2026 | 0.08 GBP |
| 6/1/2026 | 0.08 GBP |
| 5/29/2026 | 0.08 GBP |
| 5/28/2026 | 0.08 GBP |
| 5/27/2026 | 0.08 GBP |
| 5/26/2026 | 0.08 GBP |
| 5/22/2026 | 0.07 GBP |
| 5/21/2026 | 0.07 GBP |
| 5/20/2026 | 0.07 GBP |
| 5/19/2026 | 0.07 GBP |
| 5/18/2026 | 0.07 GBP |
| 5/15/2026 | 0.07 GBP |
| 5/14/2026 | 6.94 GBP |
| 5/13/2026 | 6.89 GBP |
| 5/12/2026 | 6.81 GBP |
| 5/11/2026 | 7.05 GBP |
| 5/8/2026 | 7.03 GBP |
| 5/7/2026 | 7.05 GBP |
| 5/6/2026 | 7.03 GBP |
| 5/5/2026 | 6.70 GBP |
| 5/1/2026 | 6.75 GBP |
| 4/30/2026 | 6.81 GBP |
| 4/29/2026 | 6.84 GBP |
| 4/28/2026 | 6.90 GBP |
| 4/27/2026 | 6.92 GBP |
| 4/24/2026 | 6.95 GBP |
| 4/23/2026 | 7.02 GBP |
| 4/22/2026 | 6.98 GBP |
| 4/21/2026 | 7.05 GBP |
| 4/20/2026 | 7.01 GBP |
| 4/17/2026 | 7.22 GBP |
| 4/16/2026 | 7.00 GBP |
| 4/15/2026 | 6.92 GBP |
| 4/14/2026 | 6.97 GBP |
| 4/13/2026 | 6.85 GBP |
| 4/10/2026 | 6.91 GBP |
| 4/9/2026 | 6.79 GBP |
| 4/8/2026 | 6.82 GBP |
| 4/7/2026 | 6.29 GBP |
| 4/2/2026 | 6.32 GBP |
| 4/1/2026 | 6.40 GBP |
| 3/31/2026 | 6.11 GBP |
| 3/30/2026 | 6.09 GBP |
| 3/27/2026 | 6.09 GBP |
| 3/26/2026 | 6.35 GBP |
| 3/25/2026 | 6.45 GBP |
| 3/24/2026 | 6.40 GBP |
| 3/23/2026 | 6.38 GBP |
| 3/20/2026 | 6.18 GBP |
| 3/19/2026 | 6.31 GBP |
| 3/18/2026 | 6.52 GBP |
| 3/17/2026 | 6.50 GBP |
| 3/16/2026 | 6.43 GBP |
| 3/13/2026 | 6.69 GBP |
| 3/12/2026 | 7.07 GBP |
| 3/11/2026 | 7.62 GBP |
| 3/10/2026 | 7.02 GBP |
| 3/9/2026 | 6.90 GBP |
| 3/6/2026 | 7.19 GBP |
| 3/5/2026 | 7.27 GBP |
| 2/26/2026 | 7.78 GBP |
| 2/25/2026 | 7.82 GBP |
| 2/24/2026 | 7.86 GBP |
| 2/23/2026 | 7.86 GBP |
| 2/20/2026 | 7.82 GBP |
| 2/19/2026 | 7.75 GBP |
| 2/18/2026 | 7.82 GBP |
| 2/17/2026 | 7.77 GBP |
| 2/16/2026 | 7.75 GBP |
| 2/13/2026 | 7.73 GBP |
| 2/12/2026 | 7.72 GBP |
| 2/11/2026 | 7.86 GBP |
| 2/10/2026 | 7.80 GBP |
| 2/9/2026 | 7.65 GBP |
| 2/6/2026 | 7.55 GBP |
| 2/5/2026 | 7.54 GBP |
| 2/4/2026 | 7.70 GBP |
| 2/3/2026 | 7.54 GBP |
| 2/2/2026 | 7.42 GBP |
| 1/30/2026 | 7.42 GBP |
| 1/29/2026 | 7.52 GBP |
| 1/28/2026 | 7.56 GBP |
| 1/27/2026 | 7.57 GBP |
| 1/26/2026 | 7.59 GBP |
| 1/23/2026 | 7.64 GBP |
| 1/22/2026 | 7.73 GBP |
| 1/21/2026 | 7.50 GBP |
| 1/20/2026 | 7.38 GBP |
| 1/19/2026 | 7.47 GBP |
| 1/16/2026 | 7.69 GBP |
| 1/15/2026 | 7.61 GBP |
| 1/14/2026 | 7.43 GBP |
| 1/13/2026 | 7.43 GBP |
| 1/12/2026 | 7.45 GBP |
| 1/9/2026 | 7.44 GBP |
| 1/8/2026 | 7.39 GBP |
| 1/7/2026 | 7.32 GBP |
| 1/6/2026 | 7.24 GBP |
| 1/5/2026 | 7.21 GBP |
| 1/2/2026 | 7.10 GBP |
| 12/31/2025 | 7.00 GBP |
| 12/30/2025 | 7.06 GBP |
| 12/29/2025 | 6.97 GBP |
| 12/24/2025 | 6.94 GBP |
| 12/23/2025 | 6.96 GBP |
| 12/22/2025 | 7.04 GBP |
| 12/19/2025 | 7.07 GBP |
| 12/18/2025 | 7.12 GBP |
| 12/17/2025 | 7.03 GBP |
| 12/16/2025 | 7.04 GBP |
| 12/15/2025 | 7.08 GBP |
| 12/12/2025 | 6.90 GBP |
| 12/11/2025 | 6.74 GBP |
| 12/10/2025 | 6.80 GBP |
| 12/9/2025 | 6.83 GBP |
| 12/8/2025 | 6.82 GBP |
| 12/5/2025 | 6.73 GBP |
| 12/4/2025 | 6.78 GBP |
| 12/3/2025 | 6.45 GBP |
| 12/2/2025 | 6.31 GBP |
| 12/1/2025 | 6.34 GBP |
| 11/28/2025 | 6.36 GBP |
| 11/27/2025 | 6.30 GBP |
| 11/26/2025 | 6.23 GBP |
| 11/25/2025 | 6.16 GBP |
| 11/24/2025 | 6.09 GBP |
| 11/21/2025 | 5.99 GBP |
| 11/20/2025 | 6.03 GBP |
| 11/19/2025 | 6.12 GBP |
| 11/18/2025 | 6.02 GBP |
| 11/17/2025 | 6.03 GBP |
| 11/14/2025 | 6.16 GBP |
| 11/13/2025 | 6.23 GBP |
| 11/12/2025 | 6.24 GBP |
| 11/11/2025 | 6.26 GBP |
| 11/10/2025 | 6.17 GBP |
| 11/7/2025 | 6.05 GBP |
| 11/6/2025 | 6.16 GBP |
| 11/5/2025 | 6.27 GBP |
| 11/4/2025 | 6.13 GBP |
| 11/3/2025 | 6.19 GBP |
| 10/31/2025 | 6.19 GBP |
| 10/30/2025 | 6.20 GBP |
| 10/29/2025 | 6.28 GBP |
| 10/28/2025 | 6.31 GBP |
| 10/27/2025 | 6.71 GBP |
| 10/24/2025 | 6.77 GBP |
| 10/23/2025 | 6.65 GBP |
| 10/22/2025 | 6.64 GBP |
| 10/21/2025 | 6.55 GBP |
| 10/20/2025 | 6.54 GBP |
| 10/17/2025 | 6.47 GBP |
| 10/16/2025 | 6.57 GBP |
| 10/15/2025 | 6.50 GBP |
| 10/14/2025 | 6.51 GBP |
| 10/13/2025 | 6.65 GBP |
| 10/10/2025 | 6.60 GBP |
| 10/9/2025 | 6.79 GBP |
| 10/8/2025 | 6.83 GBP |
| 10/7/2025 | 6.66 GBP |
| 10/6/2025 | 6.76 GBP |
| 10/3/2025 | 6.53 GBP |
| 10/2/2025 | 6.52 GBP |
| 10/1/2025 | 6.45 GBP |
| 9/30/2025 | 6.43 GBP |
| 9/29/2025 | 6.39 GBP |
| 9/26/2025 | 6.38 GBP |
| 9/25/2025 | 6.37 GBP |
| 9/24/2025 | 6.36 GBP |
| 9/23/2025 | 6.41 GBP |
| 9/22/2025 | 6.34 GBP |
| 9/19/2025 | 6.35 GBP |
| 9/18/2025 | 6.38 GBP |
| 9/17/2025 | 6.36 GBP |
| 9/16/2025 | 6.34 GBP |
| 9/15/2025 | 6.36 GBP |
| 9/12/2025 | 6.42 GBP |
| 9/11/2025 | 6.49 GBP |
| 9/10/2025 | 6.44 GBP |
| 9/9/2025 | 6.46 GBP |
| 9/8/2025 | 6.61 GBP |
| 9/5/2025 | 6.50 GBP |
| 9/4/2025 | 6.45 GBP |
| 9/3/2025 | 6.31 GBP |
| 9/2/2025 | 6.19 GBP |
| 9/1/2025 | 6.38 GBP |
| 8/29/2025 | 6.31 GBP |
| 8/28/2025 | 6.40 GBP |
| 8/27/2025 | 6.33 GBP |
| 8/26/2025 | 6.32 GBP |
| 8/22/2025 | 6.50 GBP |
| 8/21/2025 | 6.29 GBP |
| 8/20/2025 | 6.31 GBP |
| 8/19/2025 | 6.37 GBP |
| 8/18/2025 | 6.28 GBP |
| 8/15/2025 | 6.26 GBP |
| 8/14/2025 | 6.30 GBP |
| 8/13/2025 | 6.31 GBP |
| 8/12/2025 | 6.32 GBP |
| 8/11/2025 | 6.19 GBP |
| 8/8/2025 | 6.29 GBP |
| 8/7/2025 | 6.41 GBP |
| 8/6/2025 | 6.39 GBP |
| 8/5/2025 | 6.38 GBP |
| 8/4/2025 | 6.35 GBP |
| 8/1/2025 | 6.30 GBP |
| 7/31/2025 | 6.38 GBP |
| 7/30/2025 | 6.49 GBP |
| 7/29/2025 | 5.73 GBP |
Bodycote Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Bodycote Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM GBP |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM GBP |
| EBITM GBP |
| EBIT MARGIN% |
| NET INCOMEM GBP |
| NET INCOME GROWTH% |
| DIVIDENDDIV.GBP |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 609.00 | 567.00 | 600.00 | 690.00 | 728.00 | 719.00 | 598.00 | 615.00 | 743.00 | 802.00 | 757.00 | 725.00 | 717.00 | 732.00 | 762.00 | 792.00 |
| -1.62 | -6.90 | 5.82 | 15.00 | 5.51 | -1.24 | -16.83 | 2.84 | 20.81 | 7.94 | -5.61 | -4.23 | -1.10 | 2.09 | 4.10 | 3.94 |
| 37.27 | 36.68 | 37.00 | 37.68 | 38.05 | 37.13 | 32.11 | 38.05 | 36.20 | 37.53 | 39.10 | 39.10 | 39.10 | 39.10 | 39.10 | 39.10 |
| 227.00 | 208.00 | 222.00 | 260.00 | 277.00 | 267.00 | 192.00 | 234.00 | 269.00 | 301.00 | 296.00 | 283.49 | 280.36 | 286.22 | 297.96 | 309.69 |
| 107.00 | 97.00 | 95.00 | 119.00 | 134.00 | 130.00 | 61.00 | 81.00 | 101.00 | 119.00 | 118.00 | 88.00 | 87.00 | 89.00 | 93.00 | 96.00 |
| 17.57 | 17.11 | 15.83 | 17.25 | 18.41 | 18.08 | 10.20 | 13.17 | 13.59 | 14.84 | 15.59 | 12.14 | 12.13 | 12.16 | 12.20 | 12.12 |
| 79.00 | 56.00 | 67.00 | 97.00 | 103.00 | 93.00 | – | 59.00 | 73.00 | 85.00 | 20.00 | 82.00 | 91.00 | 103.00 | 114.00 | 133.00 |
| 8.22 | -29.11 | 19.64 | 44.78 | 6.19 | -9.71 | – | – | 23.73 | 16.44 | -76.47 | 310.00 | 10.98 | 13.19 | 10.68 | 16.67 |
| 0.15 | 0.16 | 0.15 | 0.16 | 0.18 | 0.19 | 0.13 | 0.26 | 0.20 | 0.22 | 0.23 | 0.23 | 0.24 | 0.25 | – | – |
| 7.14 | 6.67 | -6.25 | 6.67 | 12.50 | 5.56 | -31.58 | 100.00 | -23.08 | 10.00 | 4.55 | – | 4.35 | 4.17 | – | – |
| 190.24 | 189.99 | 190.17 | 190.25 | 190.29 | 190.72 | 190.37 | 190.92 | 191.36 | 190.88 | 186.88 | 186.88 | 186.88 | 186.88 | 186.88 | 186.88 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Bodycote generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Bodycote retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Bodycote's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Bodycote has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Bodycote's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Bodycote stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Bodycote Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Bodycote business model & stock analysis
Bodycote SWOT Analysis
Strengths
Bodycote PLC possesses several strengths that contribute to its success in the industry. Firstly, the company has a solid reputation and extensive experience in the thermal processing industry, making it a trusted and reliable partner for businesses seeking reliable and high-quality heat treatment services. Additionally, Bodycote PLC has a global presence with a widespread network of facilities, enabling it to serve clients internationally and tap into diverse markets. Furthermore, the company's commitment to innovation and technology-driven solutions allows it to stay ahead of competitors and offer cutting-edge processes and equipment.
Weaknesses
Despite its strengths, Bodycote PLC also faces certain weaknesses that require attention. One such weakness is its dependence on key industries such as aerospace and automotive for a significant portion of its revenue. Any downturn or instability in these sectors could impact the company's financial performance. Additionally, as a global entity, Bodycote PLC may encounter challenges associated with operating in different markets with varying regulations and cultural differences, requiring ongoing adaptation and localization efforts.
Opportunities
The thermal processing industry presents several opportunities for Bodycote PLC to capitalize on. Firstly, the increasing demand for lightweight materials and advanced manufacturing technologies opens doors for the company to provide innovative heat treatment solutions tailored to these specific needs. Moreover, the rising focus on sustainability and energy efficiency creates an opportunity for Bodycote PLC to develop and promote environmentally-friendly processes, attracting customers who prioritize ecological responsibility. Additionally, the company can explore new markets and regions, especially in emerging economies where industrial growth and demand for specialized services are on the rise.
Threats
Bodycote PLC operates in an industry that faces certain threats requiring careful consideration. One significant threat is the presence of intense competition from both established players and new entrants offering similar services. This competitiveness may lead to pricing pressures and reduced market share if not addressed adequately. Furthermore, changes in government regulations and trade policies can also pose challenges to the company's international operations, potentially affecting its ability to serve certain markets or leading to increased costs. Lastly, economic downturns or recessions can impact the overall demand for heat treatment services, affecting Bodycote PLC's financial performance.
Bodycote Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Bodycote historical P/E ratio, EBIT multiple, and P/S ratio
Bodycote annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Bodycote shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Bodycote stock splits
Bodycote Dividend History
36 years of dividend payments · 3 consecutive increases
Bodycote dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Bodycote dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Bodycote forecasts and price targets in July 2026
Analyst Price Targets 2026| Δ MOM Price Target | 1.88 % |
| Buy | 87.50 % (14) |
| Hold | 12.50 % (2) |
| Sell | 0.00 % (0) |
| 12M Price Target | 8.31 |
| Last Price | 0.07 |
| Currency | GBP |
| 12M Return Potential | 11,818.28 % |
| LTM Return | 0 % |
Bodycote Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 7/29/2022 | 0.19GBP | 347.13 MGBP | 2022 Q2 |
| 3/14/2022 | 0.17GBP | 312.42 MGBP | 2021 Q4 |
| 7/29/2021 | 0.17GBP | 315.77 MGBP | 2021 Q2 |
| 3/12/2021 | 0.16GBP | 305.51 MGBP | 2020 Q4 |
| 7/23/2020 | 0.11GBP | 285.06 MGBP | 2020 Q2 |
| 3/12/2020 | 0.27GBP | 377.38 MGBP | 2019 Q4 |
| 7/25/2019 | 0.28GBP | 385.50 MGBP | 2019 Q2 |
| 3/8/2019 | 0.26GBP | 363.92 MGBP | 2018 Q4 |
| 7/26/2018 | 0.27GBP | 375.35 MGBP | 2018 Q2 |
| 3/6/2018 | 0.30GBP | 352.00 MGBP | 2017 Q4 |
EESG©
Eulerpool ESG Scorecard© for the Bodycote stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Bodycote shareholder structure
| % | Name |
|---|---|
9.48794% | |
7.72875% | |
6.29271% | |
5.07961% | |
4.72632% | |
4.43174% |
Bodycote Executives and Management Board
Mr. Jim Fairbairn
(55)Chief Executive Officer, Executive Director · since 2024
Mr. Benjamin Fidler
Chief Financial Officer, Executive Director · since 2023
Mr. Daniel Dayan
Independent Chairman of the Board
Mr. Patrick Larmon
Non-Executive Independent Director
Mr. Kevin Boyd
Independent Non-Executive Director
Frequently asked questions about Bodycote
The business model of Bodycote PLC revolves around providing thermal processing services to various industries. Bodycote specializes in heat treatments, metal joining, and surface technology solutions. Through its global network of facilities, the company offers services like case hardening, annealing, and alloy development that enhance the properties and performance of metals and alloys. Bodycote caters to a wide range of sectors including aerospace, automotive, energy, and manufacturing. With a focus on technological advancements and customer satisfaction, Bodycote aims to deliver high-quality and tailored solutions to meet the diverse needs of its clients.
Bodycote stock
Bodycote Peer Group
Bodycote Ticker
Bodycote FIGI
All fundamentals and in-depth analysis of Bodycote
Our stock analysis for Bodycote stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bodycote. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.